Szapary D, Oshima H, Simons S S
Steroid Hormones Section, National Institute of Diabetes and Digestive and Kidney Diseases/Laboratory of Molecular and Cellular Biology, National Institutes of Health, Bethesda, Maryland 20892.
Mol Endocrinol. 1993 Aug;7(8):941-52. doi: 10.1210/mend.7.8.7901758.
Tyrosine aminotransferase (TAT), a prototypical steroid hormone-inducible gene, has been used extensively in studies of tissue-specific control of gene transcription. Over the last several years, a total of five cis-acting elements have been implicated in the tissue-specific expression and induction of the TAT gene in rat liver. These elements are all located upstream of the start of transcription, at -11, -5.5, -3.6, -2.5, and approximately -0.1 kilobases (kb). We now have used both stable and transient transfection assays to define a new element between -2.56 and -2.3 kb that regulates the fold induction by glucocorticoids in a tissue-selective manner. Compared to simple glucocorticoid-regulated constructs, which were used as controls, the major effect of this element was repression of glucocorticoid inducibility in nonliver cells. This activity was both orientation and position independent and was seen with homologous and heterologous promoters and genes. Although this element, therefore, possessed silencer-like activity, it was unable to extinguish gene expression in nonliver cells. In fact, the observance of some glucocorticoid-induced gene expression was additional evidence that the repression derived from an element that is distinct from the glucocorticoid-responsive element at -2.5 kb. A second element was found between -2.95 and -2.56 kb that acts in a tissue nonspecific manner to reduce the absolute level of gene expression in both hepatic and nonhepatic cells. The combined effects of this tissue-nonselective element and the above-mentioned tissue-selective element were to almost completely eliminate glucocorticoid inducibility in nonhepatic cells.
酪氨酸转氨酶(TAT)是一种典型的类固醇激素诱导基因,已被广泛用于基因转录的组织特异性调控研究。在过去几年中,共有五个顺式作用元件与大鼠肝脏中TAT基因的组织特异性表达和诱导有关。这些元件都位于转录起始点上游,分别在-11、-5.5、-3.6、-2.5和约-0.1千碱基(kb)处。我们现在使用稳定转染和瞬时转染实验来确定一个位于-2.56至-2.3 kb之间的新元件,该元件以组织选择性方式调节糖皮质激素的诱导倍数。与用作对照的简单糖皮质激素调控构建体相比,该元件的主要作用是抑制非肝细胞中糖皮质激素的诱导性。这种活性与方向和位置无关,在同源和异源启动子及基因中均可见。因此,尽管该元件具有类似沉默子的活性,但它无法消除非肝细胞中的基因表达。事实上,观察到一些糖皮质激素诱导的基因表达是额外的证据,表明这种抑制来自一个与-2.5 kb处的糖皮质激素反应元件不同的元件。在-2.95至-2.56 kb之间发现了第二个元件,它以组织非特异性方式起作用,降低肝和非肝细胞中基因表达的绝对水平。这个组织非选择性元件和上述组织选择性元件的联合作用几乎完全消除了非肝细胞中糖皮质激素的诱导性。